Neurons (cytology) < Neurons (drug effects) < Neurons (enzymology)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]

Ident.	Authors (with country if any)	Title
000001 (1999)	A E Kingsbury [Royaume-Uni] ; C D Marsden ; O J Foster	The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization study.
000052 (1999)	M. Merello [Argentine] ; A J Lees ; J. Balej ; A. Cammarota ; R. Leiguarda	GPi firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine.
000268 (2000)	D A Di Monte [États-Unis] ; A. Mccormack ; G. Petzinger ; A M Janson ; M. Quik ; W J Langston	Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
000433 (2001)	L. Munro-Davies [Royaume-Uni] ; J. Winter ; T Z Aziz ; J. Stein	Kainate acid lesions of the pedunculopontine region in the normal behaving primate.
000458 (2001)	H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C Hirsch	Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000499 (2001)	K P Datla [Royaume-Uni] ; S B Blunt ; D T Dexter	Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
000539 (2001)	S H Fox [Royaume-Uni] ; B. Henry ; M P Hill ; D. Peggs ; A R Crossman ; J M Brotchie	Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.
000619 (2001)	O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. Féger	Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
000656 (2002)	Annie Lannuzel [France] ; Patrick P. Michel ; Dominique Caparros-Lefebvre ; Jacqueline Abaul ; Reynald Hocquemiller ; Merle Ruberg	Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe.
000926 (2002)	Marie-Paule Muriel [France] ; Gaël Orieux ; Etienne C. Hirsch	Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
000B11 (2003)	P K Morrish	REAL and CALM: what have we learned?
000B50 (2003)	Gregor K. Wenning [Autriche] ; Felix Geser ; Michaela Stampfer-Kountchev ; François Tison	Multiple system atrophy: an update.
000D68 (2004)	Ester Fernández-Salas [États-Unis] ; Helen Ho ; Patton Garay ; Lance E. Steward ; K Roger Aoki	Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
000D70 (2004)	John A. Chaddock [Royaume-Uni] ; John R. Purkiss ; Frances C G. Alexander ; Sarah Doward ; Sarah J. Fooks ; Lorna M. Friis ; Yper H J. Hall ; Elizabeth R. Kirby ; Nicola Leeds ; Hilary J. Moulsdale ; Anthony Dickenson ; G Mark Green ; Wahida Rahman ; Rie Suzuki ; Michael J. Duggan ; Conrad P. Quinn ; Clifford C. Shone ; Keith A. Foster	Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
001053 (2005)	Günter U. Höglinger ; Patrick P. Michel ; Pierre Champy ; Jean Feger ; Etienne C. Hirsch ; Merle Ruberg ; Annie Lannuzel	Experimental evidence for a toxic etiology of tropical parkinsonism.
001087 (1992)	M A Mena [Espagne] ; B. Pardo ; M J Casarejos ; S. Fahn ; J. García De Yébenes	Neurotoxicity of levodopa on catecholamine-rich neurons.
002121 (2008)	William Jeffrey Elias [États-Unis] ; Marcel E. Durieux ; Diane Huss ; Robert C. Frysinger	Dexmedetomidine and arousal affect subthalamic neurons.
002302 (2008)	C Warren Olanow [États-Unis]	Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
002306 (2008)	Anthony A. Grace [États-Unis]	Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
002A57 (2010)	Manolo Carta [Suède] ; Thomas Carlsson ; Ana Mu Oz ; Deniz Kirik ; Anders Björklund	Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease.
002A60 (2010)	C Savio Chan [États-Unis] ; Tracy S. Gertler ; D James Surmeier	A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Neurons (drug effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Neurons (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neurons (drug effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024